Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
1
Wearable Wonders! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
13:38
13:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
13:38
This week Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, discusses advanced health tech. Dr. Kraft highlights his use of wearables like the Apple Watch, Oura ring, and non-invasive blood pressure monitors. He also introduces "otherables," which track health without being worn, using devices like cameras and modified WiFi. These technolog…
…
continue reading
1
FDA Approval! A New Model for BioPharma... Dr. Sam Blackman, Founder & Head of Research and Development, One Day Biopharmaceuticals
32:39
32:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
32:39
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. Driven by the urgent need for pediatric oncology treatments, Day One's innovative approach led to the development o…
…
continue reading
1
Robo-Docs & VR Surgery??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
13:56
13:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
13:56
This week on BioTech Nation, Dr. Moira Gunn and Dr. Daniel Kraft discuss how robotics, AI, and virtual reality are transforming surgery. These technologies make procedures less invasive and improve training and outcomes worldwide. Future advancements may include tiny robots performing internal procedures. Security is crucial to prevent hacking of m…
…
continue reading
1
No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation
16:10
16:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:10
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three t…
…
continue reading
1
Closing the Innovation Gap!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
10:26
10:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
10:26
Dr. Daniel Kraft, Tech Nation Health Chief Correspondent discusses the gap between medical innovation and its adoption into standard practice. He highlights that it typically takes 17 years for a medical discovery to become common practice, but big data and AI could accelerate this. He emphasizes the importance of sharing medical data and initiativ…
…
continue reading
1
The Virtual Cell??? Dr. Steve Quake, Head of Science at Chan Zuckerberg Initiative
21:21
21:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:21
This week, Dr. Steve Quake from the Chan Zuckerberg Initiative about their goal to tackle all human diseases in the next century. We discuss CZI's innovative approach, including building Biohubs and funding collaborative research. Dr. Quake explains the importance of something called The Virtual Cell project, aiming to use AI to model every human c…
…
continue reading
1
How Can Sound Deliver Drugs??? Dr. Neal Kassell, Founder & Chair of Focused Ultrasound Foundation
16:48
16:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:48
This week on Biotech Nation, I speak with Dr. Neal Kassell about focused ultrasound technology. We discuss its noninvasive approach, its diverse applications in treating various medical conditions, and its potential to revolutionize treatments for diseases like Alzheimer's, Parkinson's, and cancer. Dr. Kassell also shares insights into ongoing clin…
…
continue reading
1
70% of Breast Cancers and a Link to Prostate Cancer... Dr. Sean Bohen, President & CEO, Olema Oncology
23:02
23:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
23:02
This week on BioTech Nation, we explore new efforts in treating cancer with Dr. Sean Bohen, President and CEO of Olema Oncology. We discuss progress in treating breast cancer, particularly ER+/HER2- breast cancer, which accounts for 70% of diagnoses this year. They examine the biology behind these cancers and how Olema's lead compound, palazestrant…
…
continue reading
1
Tiny RNAs, Big Cures!!! Dr. Sanjay Shukla, President and CEO, ATyr (ah-tire) Pharma
19:54
19:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
19:54
This week - Dr. Sanjay Shukla, CEO of Atyr Pharma, discusses the revolutionary potential of mRNA technology in creating new medicines. They explore Atyr's pioneering approach to leveraging tRNA fragments for treating pulmonary sarcoidosis and other organ-specific conditions, aiming to improve patient outcomes while minimizing reliance on convention…
…
continue reading
1
How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics
23:33
23:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
23:33
Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the po…
…
continue reading
1
Cancer Vaccines??? Dr. Chris Pirie, Co-Founder & COO of HDT Bio
17:08
17:08
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
17:08
In this week's episode, Dr. Moira Gunn interviews Dr. Chris Pirie from HDT Bio about their novel approach to cancer prevention through vaccines. They discuss leveraging mRNA technology to target specific tumor mutations and prime the immune system to recognize and eliminate cancer cells. Dr. Pirie highlights ongoing efforts to develop vaccines for …
…
continue reading
1
Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma
15:20
15:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:20
This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations an…
…
continue reading
1
Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics
28:57
28:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
28:57
In this week's episode of BioTech Nation, Dr. David Bearss, President and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses and its potential in treating chronic dis…
…
continue reading
1
Food as Medicine, A Personalized Prescription... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
10:21
10:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
10:21
Tech Nation Health, Chief Correspondent Dr. Daniel Kraft discusses the concept of "food as medicine." Dr. Kraft emphasizes the evolving understanding of nutrition and its profound impact on health, advocating for a shift towards personalized nutrition using cutting-edge technologies. From continuous glucose monitors to AI-powered apps and sensor to…
…
continue reading
1
Repairing Minds, Naturally??? Mark Litton, President & CEO, Athira Pharma
22:38
22:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:38
Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litt…
…
continue reading
1
Combatting Blood Clots!!! Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics
14:31
14:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
14:31
This week, Dr. Daniel Bloomfield from Anthos Therapeutics discusses the prevalence and dangers of blood clots, particularly in patients with cancer. Dr. Bloomfield explains the difference between normal and abnormal blood clotting, the risks associated with blood clots in arteries and veins, and the challenges in balancing clot prevention with the …
…
continue reading
1
Heartburn, GERD, Cancer??? Dr. Lishan Aklog, CEO of Lucid Diagnostics
22:59
22:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:59
Dr. Lishan Aklog from Lucid Diagnostics tells us about the path from GERD to, unfortunately, esophageal cancer, and about Lucid’s two-minute diagnostic test which can detect precancerous cells.بقلم Moira Gunn
…
continue reading
1
From Tummy Tucks to Drug Trials??? Dr. Eric Merle, Chief Business Innovation Officer, GenoSkin
14:23
14:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
14:23
Dr. Eric Merle from GenoSkin talks about how they are transforming drug discovery using discarded human skin from surgeries like tummy tucks, revolutionizing the process and accelerating drug development timelines.بقلم Moira Gunn
…
continue reading
1
One Drug, Many Diseases??? Dr. David Fajgenbaum, UPenn School of Medicine Professor and President of Every Cure
27:56
27:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
27:56
Not just seeking treatment for every disease, but making sure the treatments we have already developed are being used in every possible way. I speak with Dr. David Fajgenbaum (Fay-gen-baum), a Professor of Translational Medicine and Human Genetics at the University of Pennsylvania School of Medicine, and President of Every Cure.…
…
continue reading
1
Alcohol-Associated Hepatitis Treatment on the Horizon!!! Dr. Jim Brown, CEO of DURECT
14:52
14:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
14:52
Dr. Jim Brown from DURECT talks about their clinical trials for Alcohol-Associated Hepatitis, a condition for which there is no approved treatment.بقلم Moira Gunn
…
continue reading
1
Building Technology and Solving Problems!!! Dave Pacitti, President & Head of the Americas, Siemens Healthineers
20:30
20:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:30
When is a medical technology company more than a medical technology company? We’ll hear all about it when I speak with Dave Pacitti, the President and Head of the Americas at Siemens Healthineers. They’re out to solve problems bigger than the products they are known for.بقلم Moira Gunn
…
continue reading
1
XPrize Foundation and $101 Million!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
11:14
11:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
11:14
Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the newest XPrize worth an unprecedented $101 Million.بقلم Moira Gunn
…
continue reading
1
Wound Healing 2.0!!! Dr. Nik Sopko, Chief Scientific Officer at PolarityTE
15:19
15:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:19
Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers.بقلم Moira Gunn
…
continue reading
1
Harnessing Natural Killer Cells!!! Dr. Eric Vivier, SVP & CSO of Innate Pharma
20:25
20:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
20:25
Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.بقلم Moira Gunn
…
continue reading
1
Can Every Medicine Be a Pill??? Dr. Ray Stevens, CEO of ShouTi Pharma
24:24
24:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:24
Dr. Ray Stevens, CEO of ShouTi Pharma, talks about their approach in turning IV drugs into pills. Current projects include Diabetes and obesity, and two Pulmonary and Cardiovascular disorders. And these are just their first candidates …بقلم Moira Gunn
…
continue reading
1
Gut-Brain Connections to Autism, Parkinson's, and More!!! Dr. Stewart Campbell, CEO Axial Therapeutics
25:38
25:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
25:38
Dr. Stewart Campbell, CEO of Axial Therapeutics, about their groundbreaking work in Autism–related irritability in teenagers, in Parkinson’s, and in complementing the latest cancer treatments.بقلم Moira Gunn
…
continue reading
1
Ancient Viruses in our DNA??? Dr. Neil Shubin, Professor & Author University of Chicago
28:55
28:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
28:55
On this week’s BioTech Nation University of Chicago professor Dr. Neil Shubin talks about his book “Some Assembly required … Decoding Four Billion Years of Life, from Ancient Fossils to DNA.” Ancient viruses in our DNA? And what about “jumping genes”?بقلم Moira Gunn
…
continue reading
1
Treating Diseases with Brain Implants??? Nicolas Vachicouras, CEO & Co-Founder Neurosoft Bioelectronics
15:44
15:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
15:44
This week we visit the brain, and look at what a flexible brain implant might do – from sensing how your brain is working to actual treatment. Nicolas Vachicouras from Neurosoft Bioelectronics in Geneva, Switzerland talks about the target for their first treatment: severe tinnitus.بقلم Moira Gunn
…
continue reading
1
The Next Ozempic or Wegovy... But Without the Injection??? Dr. Steffen-Sebastian Bolz, CSO, Aphaia (ah-phi-ah) Pharma
24:36
24:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:36
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.بقلم Moira Gunn
…
continue reading
1
Who Could Forget About Dolly The Sheep??? Sir Ian Wilmut, Director, Scottish Centre for Regenerative Medicine
29:51
29:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:51
We honor Sir Ian Wilmut, the Scottish embryologist who gained worldwide renown as the leader of the scientific research group that cloned the equally famous Dolly. With his recent passing, we air our 2007 BioTech Nation interview, when David Ewing Duncan and I spoke with Dr. Wilmut on the 10th anniversary of Dolly’s birth.…
…
continue reading
1
Everybody Has a Thyroid... What Could Go Wrong??? Dr. Mark Sumeray, CMO of Amolyt Pharma
28:19
28:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
28:19
Dr. Mark Sumeray from Amolyt Pharma talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.بقلم Moira Gunn
…
continue reading
1
It’s All About Cancer, and Covid??? Dr. Andrew Allen, President, CEO, & Co-Founder Gritstone Bio
43:28
43:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
43:28
This week on BioTech Nation, Andrew Allen, President, CEO and Co-Founder of Gritstone Bio – a full spectrum look at how cancer starts and cancer treatments have developed … and what next-generation treatment means today with Gritstone’s work in colorectal cancer. And wait for it … the next generation of Covid vaccines.…
…
continue reading
1
Is Medical School Curriculum Outdated??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
11:43
11:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
11:43
Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about how Medical Schools decide what to teach. You might be surprised that it’s based on the Flexner Report … written in … 1910. Is it time for a do-over? And what might that be?بقلم Moira Gunn
…
continue reading
1
Your Digital Twin May Already Exist!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
6:50
6:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
6:50
Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about your Digital Twin … your Digital Twin … yes, you have one.بقلم Moira Gunn
…
continue reading
1
A New Approach To Treating Diabetes... Dr. Anthony Japour, President & CEO, iTolerance
12:40
12:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
12:40
Dr. Anthony Japour, President and CEO from iTolerance in Miami, Florida tells us about implanting insulin-producing cells in your pancreas – it’s been tried before, but they have a new approach which just might work.بقلم Moira Gunn
…
continue reading
1
What's New in Digital Health!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
11:17
11:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
11:17
Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the explosion of digital health.بقلم Moira Gunn
…
continue reading
1
Google's First Radio Interview Ever!!! Larry Page & Sergey Brin, Co-Founders, Google
28:15
28:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
28:15
It’s the 25th anniversary of the founding of Google … and 23 years ago, Google founders - Larry Page and Sergey Brin – came to the Tech Nation studios to do their very first radio interview. There’s lots to learn there, including they believed what humans demanded of search, and why they did what they did.…
…
continue reading
1
Old Dog, New Tricks ??? ... Dr. Robert Ladner, CEO & Founder, CV6 Therapeutics
21:11
21:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:11
Dr. Robert Ladner, the Founder of CV6 Therapeutics in Belfast, Northern Ireland, tells us about their work to make a cornerstone cancer chemotherapy, even more effective. First trials are in colorectal and gastrointestinal cancers...بقلم Moira Gunn
…
continue reading
1
Can Good Viruses Kill Deadly Infections??? Tom Ireland, Science Journalist & Author
28:57
28:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
28:57
Science journalist Tom Ireland tells us about a burgeoning field of science, which is changing the fight to successfully treat antibiotic infections. His book is “The Good Virus: The Amazing Story and Forgotten Promise of the Phage”.بقلم Moira Gunn
…
continue reading
1
Osteoarthritis... Mostly in the Knee, But Pick a Joint!!! Dr. Diem Nguyen, CEO of Xalud Therapeutics
18:39
18:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:39
Osteoarthritis – mostly in the knee, but pick a joint. Dr. Diem (Zem) Nguyen (N’Win) is the CEO of Xalud (Za-lood) Therapeutics. We’ll talk about their work to reduce the inflammation that drives pain. It’s now in human clinical trials.بقلم Moira Gunn
…
continue reading
1
Why Do AI One Way, When You Can Do it 25??? Dr. Ben Thomas and Dermot Tierney, CEO & CCO, Amply Discovery
21:49
21:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
21:49
Why use one AI approach when you can use 25? CEO Dr. Ben Thomas and Chief Commercial Officer Dermot Tierney from Amply Discovery talks about how their novel approach to AI in drug discovery.بقلم Moira Gunn
…
continue reading
1
Acute Cannabis Intoxication... Is There An Antidote??? Dr. Ken Cundy, CSO at Anebulo Pharmaceuticals
18:53
18:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
18:53
Modern cannabis products, with higher potency than those from the past, can lead to acute cannabis intoxication. Anebulo Pharmaceuticals, led by Chief Scientific Officer Dr. Ken Cundy, is working on an antidote that counteracts the negative effects of THC overdose, potentially benefiting both adults and children.…
…
continue reading
1
Did That Change To My Prescription Work??? -- Dr. Kal Patel, CEO, BrightInsight
35:13
35:13
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:13
Continuous monitoring ... when we want it, when we don’t, should we share it? Or not. Or perhaps just part of it. Dr. Kal Patel, the Co-Founder and CEO of BrightInsight talks about this brave new frontier.بقلم Moira Gunn
…
continue reading
1
Gliobastoma + New View on Clinical Trials... Dr. Fahar Merchant, President & CEO Medicenna Therapeutics
22:38
22:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
22:38
Glioblastoma is the most aggressive form of brain cancer, and progress in treating Glioblastoma has been elusive. Now, Toronto-based Medicenna has completed a successful Phase 2 with its innovative drug, and is now deep into planning the Phase 3 Trial. Also of interest, the FDA agreed to an unprecedented approach in Phase 2, which not only yields b…
…
continue reading
1
Innovation in Head & Neck Cancers!!! Dr. Mark Newman, CSO, GeoVax
14:40
14:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
14:40
In this week's BioTech Nation, we discuss Geovax, a company working on a novel approach to treat head and neck cancers, which are often difficult to treat after standard options have been exhausted. Geovax is developing A2 component therapy, using an enzyme delivered directly to the tumor by a needle injection, followed by an infusion of an inactiv…
…
continue reading
1
We Still Can't Ignore Long Covid... Dr. Jeffrey Cleland, CEO Ashvattha Therapeutics
9:54
9:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
9:54
In this week's episode of Biotech Nation, Dr. Jeffrey Cleland, the President and CEO of Ashvattha Therapeutics, discusses their drug development efforts to address long COVID. They discuss the definition of long COVID by the World Health Organization, the prevalence of the condition, and the chronic inflammation that occurs in the body, including t…
…
continue reading
1
Can The Time Needed for CAR-T be shortened? EXUMA Says Yes!!! Dr. Gregory Frost, CEO, EXUMA Biotech
10:21
10:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
10:21
In this week's episode of Biotech Nation, Dr. Greg Frost, CEO of Exuma Biotech, discusses their innovative approaches to cancer treatment. They are working on a method to shorten the time and eliminate hospital stays for CAR-T therapy, while also developing a new technology called G-car that combines T cells and NK cells to create a more gentle and…
…
continue reading
1
Temporal Lobe Epilepsy - TLE - Will Cell Therapy Work??? Dr. Cory Nicholas, CEO, Neurona Therapeutics
24:21
24:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
24:21
A new cell therapy, just entering human clinical trials. It focuses on a particular type of Epilepsy - Temporal Lobe Epilepsy. I speak with Dr. Cory Nicholas, the Co-Founder and CEO of Neurona Therapeutics, about their idea, what they’ve done, and how they plan to approach testing this unprecedented treatment.…
…
continue reading
1
New Hope For Glaucoma... Dr. Chris Nave, Managing Director of Brandon Capital and Chair of PolyActiva
9:12
9:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
9:12
Join us as Dr. Chris Nave, the managing director of Brandon Capital and Chair of PolyActiva, reveals groundbreaking advancements in eye treatments on this week's episode of Biotech Nation! Discover how their innovative technology is revolutionizing the way we deliver drugs to the eye, offering extended therapy periods and eliminating the need for f…
…
continue reading
1
The Beauty Contest... Winner Goes to Phase I - Dr. Richard Austin, Founder & CEO Reglagene
16:36
16:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
16:36
Join Dr. Richard Austin, Founder and CEO of Reglagene, as he reveals the intense process of selecting the most promising drug candidate for treating brain cancer. Delve into the intriguing world of the "Bake Off" or "beauty contest" where molecules compete to be the breakthrough therapy in human clinical trials. Discover the challenges of penetrati…
…
continue reading